General

Showing 1249–1264 of 2270 results

• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New perspectives with PI3K inhibitors in B-cell malignant hemopathies

  €3.03 Add to cart
• 

  Article: New therapeutic approaches in cutaneous T-cell lymphomas

  €3.03 Add to cart
• 

  Article: New therapeutic approaches in cutaneous T-cell lymphomas

  €3.03 Add to cart
• 

  Article: NEW TREATMENT OPPORTUNITIES WITH EHL PRODUCTS IN HAEMOPHILIA B

  €3.03 Add to cart
• 

  Article: New treatment options for patients with inadequately controlled polycythemia vera

  €3.03 Add to cart
• 

  Article: News in sickle cell disease

  €3.03 Add to cart
• 

  Article: NGS: investing in deeper evaluation and optimised therapeutic decisions in myeloid neoplasms

  €3.03 Add to cart
• 

  Article: Nivolumab improves survival in non-squamous NSCLC

  €3.03 Add to cart
• 

  Article: Nivolumab in patients with relapsed or refractory classical Hodgkin Lymphoma

  €3.03 Add to cart
• 

  Article: Nivolumab is safe and effective in patients with relapsed/refractory lymphoid malignancies and classical Hodgkin lymphoma

  €3.03 Add to cart
• 

  Article: Nivolumab prolongs the survival of patients with advanced renal cell cancer

  €3.03 Add to cart
• 

  Article: Non-muscle myosin IIA, a new potential molecular target to improve radiotherapy outcome for breast cancer patients

  €3.03 Add to cart